DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
出版年份 2019 全文链接
标题
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
作者
关键词
-
出版物
Epigenetics
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2019-12-03
DOI
10.1080/15592294.2019.1699991
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness
- (2019) Vijayalakshmi Kari et al. Clinical Epigenetics
- Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells
- (2019) Giovanni Nassa et al. Science Advances
- Structural Basis for Recognition of Ubiquitylated Nucleosome by Dot1L Methyltransferase
- (2019) Cathy J. Anderson et al. Cell Reports
- The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection
- (2019) Xiangyu Chen et al. Cellular & Molecular Immunology
- Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L‐dose dependency in HDAC1‐deficient thymic lymphoma
- (2019) Hanneke Vlaming et al. EMBO JOURNAL
- The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
- (2018) Eytan M. Stein et al. BLOOD
- Structural and functional analysis of the DOT1L–AF10 complex reveals mechanistic insights into MLL-AF10-associated leukemogenesis
- (2018) Heng Zhang et al. GENES & DEVELOPMENT
- The protective role of DOT1L in UV-induced melanomagenesis
- (2018) Bo Zhu et al. Nature Communications
- Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges
- (2018) Yuchen Chen et al. Computational and Structural Biotechnology Journal
- Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
- (2018) Subhankar Biswas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Peptidomimetics for Targeting Protein–Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL
- (2018) Lei Du et al. ACS Medicinal Chemistry Letters
- Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia
- (2017) Hiroshi Okuda et al. JOURNAL OF CLINICAL INVESTIGATION
- The MLL recombinome of acute leukemias in 2017
- (2017) C Meyer et al. LEUKEMIA
- Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in MLL -Rearranged Leukemia
- (2017) Carly T. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells
- (2017) Stephen Wilson et al. Oncotarget
- DOT1L as a therapeutic target for the treatment of DNMT3A -mutant acute myeloid leukemia
- (2016) Rachel E. Rau et al. BLOOD
- Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological Assays
- (2016) Shijie Chen et al. Journal of Chemical Information and Modeling
- Functional interdependence of BRD4 and DOT1L in MLL leukemia
- (2016) Omer Gilan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach
- (2016) Chao Chen et al. ACS Medicinal Chemistry Letters
- ‘Acute myeloid leukemia: a comprehensive review and 2016 update’
- (2016) I De Kouchkovsky et al. Blood Cancer Journal
- Functional interdependence of BRD4 and DOT1L in MLL leukemia
- (2016) Omer Gilan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond
- (2015) Chun-Wei Chen et al. EXPERIMENTAL HEMATOLOGY
- Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target
- (2015) Nigel J. Waters et al. JOURNAL OF CONTROLLED RELEASE
- Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitor
- (2014) Aravind Basavapathruni et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Functional characterisation of different MLL fusion proteins by using inducible Sleeping Beauty vectors
- (2014) K. Wächter et al. CANCER LETTERS
- AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation
- (2014) Yuanyuan Li et al. CELL
- DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
- (2014) M. Annala et al. EMBO Molecular Medicine
- Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States
- (2014) Dianne Pulte et al. PLoS One
- DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
- (2014) Wei Liu et al. PLoS One
- Direct interactions promote eviction of the Sir3 heterochromatin protein by the SWI/SNF chromatin remodeling enzyme
- (2014) Benjamin J. Manning et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1
- (2013) Kyle D. Konze et al. ACS Chemical Biology
- Bromo-deaza-SAH: A potent and selective DOT1L inhibitor
- (2013) Wenyu Yu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Chromatin Remodeling at DNA Double-Strand Breaks
- (2013) Brendan D. Price et al. CELL
- Protein arginine methylation of non-histone proteins and its role in diseases
- (2013) Han Wei et al. CELL CYCLE
- Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines
- (2013) Tao Li et al. HUMAN MOLECULAR GENETICS
- A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1L
- (2013) Justin L. Anglin et al. JOURNAL OF MEDICINAL CHEMISTRY
- The MLL recombinome of acute leukemias in 2013
- (2013) C Meyer et al. LEUKEMIA
- Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity
- (2013) S. Jorgensen et al. NUCLEIC ACIDS RESEARCH
- Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations
- (2013) Hong Wu et al. PLoS One
- Epigenetics in Saccharomyces cerevisiae
- (2013) M. Grunstein et al. Cold Spring Harbor Perspectives in Biology
- ATM Release at Resected Double-Strand Breaks Provides Heterochromatin Reconstitution to Facilitate Homologous Recombination
- (2013) Verena Geuting et al. PLoS Genetics
- S-Adenosyl-Methionine-Dependent Methyltransferases: Highly Versatile Enzymes in Biocatalysis, Biosynthesis and Other Biotechnological Applications
- (2012) Anna-Winona Struck et al. CHEMBIOCHEM
- Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases
- (2012) Timothy P Wakeman et al. EMBO JOURNAL
- The N676D and G697R mutations in the kinase domain of FLT3 confer resistance to the inhibitor AC220
- (2012) D. Pauwels et al. HAEMATOLOGICA
- Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors
- (2012) A B Williams et al. LEUKEMIA
- Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
- (2012) Joshua C. Black et al. MOLECULAR CELL
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
- (2012) Wenyu Yu et al. Nature Communications
- Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation
- (2011) S. Y. Jo et al. BLOOD
- DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
- (2011) A. T. Nguyen et al. BLOOD
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- (2011) Masashi Takawa et al. CANCER SCIENCE
- Essential role of DOT1L in maintaining normal adult hematopoiesis
- (2011) Anh T Nguyen et al. CELL RESEARCH
- Deficiency of H3K79 Histone Methyltransferase Dot1-like Protein (DOT1L) Inhibits Cell Proliferation
- (2011) Wootae Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Methyltransferase SETD3 Regulates Muscle Differentiation
- (2011) Gwang Hyeon Eom et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies
- (2011) Yuan Yao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia
- (2011) B V Balgobind et al. LEUKEMIA
- Dot1 and Histone H3K79 Methylation in Natural Telomeric and HM Silencing
- (2011) Yoh-Hei Takahashi et al. MOLECULAR CELL
- A Common Telomeric Gene Silencing Assay Is Affected by Nucleotide Metabolism
- (2011) Marlies P. Rossmann et al. MOLECULAR CELL
- Catalytic Mechanism Investigation of Lysine-Specific Demethylase 1 (LSD1): A Computational Study
- (2011) Xiangqian Kong et al. PLoS One
- The AF4{middle dot}MLL fusion protein is capable of inducing ALL in mice without requirement of MLL{middle dot}AF4
- (2010) A. Bursen et al. BLOOD
- MLL-AF9-Induced Leukemogenesis Requires Coexpression of the Wild-Type Mll Allele
- (2010) Austin T. Thiel et al. CANCER CELL
- Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group
- (2010) A. Oriol et al. HAEMATOLOGICA
- Overexpression ofgrappaencoding a histone methyltransferase enhances stress resistance inDrosophila
- (2009) Olivier List et al. HEREDITAS
- Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation
- (2008) Ali Shilatifard CURRENT OPINION IN CELL BIOLOGY
- Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
- (2008) M. G. Guenther et al. GENES & DEVELOPMENT
- DOT1L/KMT4 Recruitment and H3K79 Methylation Are Ubiquitously Coupled with Gene Transcription in Mammalian Cells
- (2008) D. J. Steger et al. MOLECULAR AND CELLULAR BIOLOGY
- Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation
- (2008) Robert K. McGinty et al. NATURE
- Nonprocessive methylation by Dot1 leads to functional redundancy of histone H3K79 methylation states
- (2008) Floor Frederiks et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
- The Histone H3K79 Methyltransferase Dot1L Is Essential for Mammalian Development and Heterochromatin Structure
- (2008) Brendan Jones et al. PLoS Genetics
- Chronic Myeloid Leukemia Stem Cells
- (2008) C. H. Jamieson Hematology-American Society of Hematology Education Program
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More